基于免疫联合靶向方案的晚期肝细胞癌转化治疗中国专家共识（2021版）
中华预防医学会肝胆胰疾病预防与控制专业委员会, 中国抗癌协会肝癌专业委员会, 北京医学会外科学分会肝脏学组, 《中华肝胆外科杂志》编辑委员会
Chinese expert consensus on conversion therapy of immune checkpoint inhibitors combined antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2021 Edition)
Professional Committee for Prevention and Control of Hepatobiliary and Pancreatic Diseases of Chinese Preventive Medicine Association; Chinese Society of Liver Cancer, Chinese Anti-Cancer Association; Liver Study Group of Surgery Committee of Beijing Medical Association; Editorial Board of Chinese Journal of Hepatobiliary Surgery
肝癌电子杂志
.
2021, (2): 6
-15
.
